| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,052 |
2,022 |
$207K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,782 |
2,720 |
$156K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,735 |
1,677 |
$80K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
758 |
757 |
$64K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
575 |
575 |
$48K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
796 |
788 |
$41K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
384 |
382 |
$31K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,853 |
2,850 |
$26K |
| 90461 |
|
681 |
680 |
$24K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,200 |
2,195 |
$23K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
191 |
191 |
$15K |
| 92552 |
|
389 |
389 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
97 |
97 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
270 |
266 |
$9K |
| 99173 |
|
297 |
297 |
$7K |
| 96127 |
|
432 |
432 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
144 |
144 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
241 |
241 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
137 |
135 |
$3K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
120 |
120 |
$2K |
| 0072A |
|
38 |
38 |
$2K |
| 99050 |
|
100 |
100 |
$2K |
| 99051 |
|
87 |
86 |
$1K |
| 0071A |
|
27 |
27 |
$1K |
| 87081 |
|
153 |
153 |
$1K |
| 87634 |
|
15 |
15 |
$928.80 |
| 85018 |
|
170 |
170 |
$382.65 |
| 99188 |
|
12 |
12 |
$312.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12 |
12 |
$237.12 |